search
Back to results

Long-term Impact and Intervention for Diarrhea in Brazil

Primary Purpose

Diarrheal Disorder

Status
Unknown status
Phase
Phase 3
Locations
Brazil
Study Type
Interventional
Intervention
Glutamine
Vitamin A
glycine
zinc
Sponsored by
University of Virginia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diarrheal Disorder focused on measuring Brazil, Child Nutrition Disorders, Deficiency Diseases

Eligibility Criteria

2 Months - 8 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Children ages 2 months to 8 years with height for age Z-score (HAZ) less than the median for the Parque Universitario community. Be a resident in Brazilian flavela. Child's parent or guardian must sign informed consent. Exclusion Criteria: Children exclusively breast-fed. Children who participated in the "hospital study" or any other study with in the past two years. Children with fever > 102 F at time of screening. Children with systemic disease at the time of screening including but not limited to: shock, meningitis, sepsis, pneumonia, tuberculosis, varicella. Children on antibiotics during screening. Children with siblings from the same household enrolled in this study.

Sites / Locations

  • Federal University of CearáRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Active Comparator

Placebo Comparator

Placebo Comparator

Experimental

Arm Label

a

b

c

d

e

f

Arm Description

oral glutamine with juice for 10 days

PO vit A q 4 mo for 1 year plus zinc placebo

Zinc 40 mg twice weekly Plus Vitamin A Placebo for one year

oral glycine with juice daily for 10 days

Vitamin A Placebo plus Zinc Placebo for one year

Vitamin A q 4 months and PO Zinc for 1 year

Outcomes

Primary Outcome Measures

L:M ratio at 1.5 months

Secondary Outcome Measures

L:M ratio at 4 & 12 months
HAZ
Diarrhea burden

Full Information

First Posted
August 19, 2005
Last Updated
March 4, 2011
Sponsor
University of Virginia
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
search

1. Study Identification

Unique Protocol Identification Number
NCT00133406
Brief Title
Long-term Impact and Intervention for Diarrhea in Brazil
Official Title
Long-term Impact and Intervention for Diarrhea in Brazil
Study Type
Interventional

2. Study Status

Record Verification Date
March 2011
Overall Recruitment Status
Unknown status
Study Start Date
June 2006 (undefined)
Primary Completion Date
December 2011 (Anticipated)
Study Completion Date
December 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
University of Virginia
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system.
Detailed Description
Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. Subjects will be enrolled into this prospective, randomized, placebo controlled study of the Long-term Impact and Intervention for Diarrhea in Brazil. Children meeting the inclusion criteria will be prospectively, randomized to four arms: (1) placebo: placebo (2) Vitamin A: Zinc Placebo (3) Vitamin A Placebo:Zinc (4) Vitamin A:Zinc. Intervention will last for one year with two additional years of follow up. A nested study involving all patients will take place at week four. At week four there will be a second randomization to either oral glutamine or glycine (placebo) for an additional ten days. The primary endpoint of the nested study will be the L:M ratio at 6 weeks. The master randomization list will be broken, only by combined approval of the Principal Investigators, at the end of the study or in the unexpected event of a child needing removal from the study (for that case only). All randomized subjects will be visited in their home two times per week for assessment of intercurrent diarrhea. At 1, 4, 8, 12, 24 and 36 months patients will have a nutritional status/anthropometry and diarrheal illness rate assessment. At 0, 1, 1.5, and 4 months all randomized subjects will have a Lactulose:Mannose Ratio (L:M) performed. A blood Zinc and Vitamin A level will be drawn at 0 and 4 months. Also a stool microbiology, lactoferrin and protein loss assessment will be completed at 1 month. All randomized subjects who complete the protocol should have assessments as outlined above at 36 weeks. The primary effect of interest is the difference in mean HAZ changes between children receiving Zinc plus Vitamin A compared to children receiving no Vitamin A or Zinc, averaging the difference in children receiving glutamine and children not receiving glutamine.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diarrheal Disorder
Keywords
Brazil, Child Nutrition Disorders, Deficiency Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
321 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
a
Arm Type
Experimental
Arm Description
oral glutamine with juice for 10 days
Arm Title
b
Arm Type
Experimental
Arm Description
PO vit A q 4 mo for 1 year plus zinc placebo
Arm Title
c
Arm Type
Active Comparator
Arm Description
Zinc 40 mg twice weekly Plus Vitamin A Placebo for one year
Arm Title
d
Arm Type
Placebo Comparator
Arm Description
oral glycine with juice daily for 10 days
Arm Title
e
Arm Type
Placebo Comparator
Arm Description
Vitamin A Placebo plus Zinc Placebo for one year
Arm Title
f
Arm Type
Experimental
Arm Description
Vitamin A q 4 months and PO Zinc for 1 year
Intervention Type
Drug
Intervention Name(s)
Glutamine
Intervention Description
0.8gm/kg, ie up to a total daily dose of 16.2gm/day,with juice daily for 10 days
Intervention Type
Drug
Intervention Name(s)
Vitamin A
Intervention Description
100,000 IU for children under 12 months of age (or placebo) and PO 200,000 IU for children at least 12 months of age (or placebo), both q months for 1 year at 0, 4 and 8 months.
Intervention Type
Drug
Intervention Name(s)
glycine
Intervention Description
0.4gm/kg; ie up to 8.3gm/d, with juice daily for 10 days
Intervention Type
Drug
Intervention Name(s)
zinc
Intervention Description
40 mg twice weekly for 12 months
Primary Outcome Measure Information:
Title
L:M ratio at 1.5 months
Time Frame
1.5 months
Secondary Outcome Measure Information:
Title
L:M ratio at 4 & 12 months
Time Frame
4 and 12 months
Title
HAZ
Time Frame
1.5, 4, 8, 12, 24, and 36 months
Title
Diarrhea burden
Time Frame
4, 8, 12, 24, and 36 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Months
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children ages 2 months to 8 years with height for age Z-score (HAZ) less than the median for the Parque Universitario community. Be a resident in Brazilian flavela. Child's parent or guardian must sign informed consent. Exclusion Criteria: Children exclusively breast-fed. Children who participated in the "hospital study" or any other study with in the past two years. Children with fever > 102 F at time of screening. Children with systemic disease at the time of screening including but not limited to: shock, meningitis, sepsis, pneumonia, tuberculosis, varicella. Children on antibiotics during screening. Children with siblings from the same household enrolled in this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Richard Guerrant
Phone
(434) 924-5242
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard L Guerrant, MD
Organizational Affiliation
University of Virginia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Federal University of Ceará
City
Fortaleza
ZIP/Postal Code
60436160
Country
Brazil
Individual Site Status
Recruiting

12. IPD Sharing Statement

Citations:
PubMed Identifier
24714829
Citation
Lima AA, Anstead GM, Zhang Q, Figueiredo IL, Soares AM, Mota RM, Lima NL, Guerrant RL, Oria RB. Effects of glutamine alone or in combination with zinc and vitamin A on growth, intestinal barrier function, stress and satiety-related hormones in Brazilian shantytown children. Clinics (Sao Paulo). 2014;69(4):225-33. doi: 10.6061/clinics/2014(04)02.
Results Reference
derived
PubMed Identifier
23644855
Citation
Lima AA, Kvalsund MP, Souza PP, Figueiredo IL, Soares AM, Mota RM, Lima NL, Pinkerton RC, Patrick PP, Guerrant RL, Oria RB. Zinc, vitamin A, and glutamine supplementation in Brazilian shantytown children at risk for diarrhea results in sex-specific improvements in verbal learning. Clinics (Sao Paulo). 2013;68(3):351-8. doi: 10.6061/clinics/2013(03)oa11.
Results Reference
derived
PubMed Identifier
22249475
Citation
Mitter SS, Oria RB, Kvalsund MP, Pamplona P, Joventino ES, Mota RM, Goncalves DC, Patrick PD, Guerrant RL, Lima AA. Apolipoprotein E4 influences growth and cognitive responses to micronutrient supplementation in shantytown children from northeast Brazil. Clinics (Sao Paulo). 2012;67(1):11-8. doi: 10.6061/clinics/2012(01)03.
Results Reference
derived
PubMed Identifier
20038852
Citation
Lima AA, Soares AM, Lima NL, Mota RM, Maciel BL, Kvalsund MP, Barrett LJ, Fitzgerald RP, Blaner WS, Guerrant RL. Effects of vitamin A supplementation on intestinal barrier function, growth, total parasitic, and specific Giardia spp infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):309-15. doi: 10.1097/MPG.0b013e3181a96489.
Results Reference
derived

Learn more about this trial

Long-term Impact and Intervention for Diarrhea in Brazil

We'll reach out to this number within 24 hrs